Number of clinical trials in Finland falls in 2007
This article was originally published in Scrip
The number of clinical trials conducted in Finland last year fell to 459 from above 500 in 2006, which was an “exceptionally high” number, says Pharma Industry Finland, the national association. One quarter (115) of them involved medicines for CNS disorders, followed by 104 trials for cancer and substances modulating the immune system response. 175 new trials were initiated in 2007 which was nearly an average figure. The number of patients enrolled increased by around 20% to 48,000, with half of them taking part in Phase III trials and almost 40% in Phase IV trials. The majority (80%) were involved in vaccine trials. In the six years to 2007, clinical trials of vaccines prevailed over other products, with seven to 19 studies being conducted in this group every year. Children participated in those of rotavirus, varicella, influenza and human papillomavirus vaccines.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.